Cargando…

Serum Hyaluronic Acid as a Noninvasive Marker of Hepatic Fibrosis in Chronic Hepatitis B

BACKGROUND/AIMS: Chronic hepatitis B is a serious global health problem. Liver biopsy is currently recommended as the gold standard for the evaluation of the degree of fibrosis in patients with chronic hepatitis B. This procedure, however, is invasive and has potential complications. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geramizadeh, Bita, Janfeshan, Katayoun, Saberfiroozi, Mehdi
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702931/ https://www.ncbi.nlm.nih.gov/pubmed/19568533 http://dx.doi.org/10.4103/1319-3767.43274

Ejemplares similares

Serum Hyaluronic Acid: A Promising Marker of Hepatic Fibrosis in Chronic Hepatitis B
por: Shiha, Gamal
Publicado: (2008)

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B
por: Poynard, Thierry, et al.
Publicado: (2011)

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B
por: Montazeri, Ghodrat, et al.
Publicado: (2005)

Serum Gamma-Glutamyl Transpeptidase-to-Platelet Ratio as a Noninvasive Marker of Liver Fibrosis in Chronic Hepatitis B
por: Purkayastha, Subham, et al.
Publicado: (2023)

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
por: Zeremski, Marija, et al.
Publicado: (2014)

Determination of the Relationship of Serum Hyaluronic Acid Levels to the Degree of Liver Fibrosis in Biopsies of Patients with Chronic Viral Hepatitis B and C
por: Moghaddam, Faride Moradi, et al.
Publicado: (2010)

Evaluation of fibrosis with noninvasive biochemical tests in chronic viral hepatitis B
por: Kaya, Adem, et al.
Publicado: (2023)

Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B
por: Liu, Jianxue, et al.
Publicado: (2016)

Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients.
por: Granot, E, et al.
Publicado: (2001)

Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
por: Li, Wenhao, et al.
Publicado: (2020)

Noninvasive Assessment of Hepatic Fibrosis in Patients with Chronic Hepatitis B Viral Infection Using Magnetic Resonance Elastography
por: Lee, Jeong Eun, et al.
Publicado: (2014)

RDW to Platelet Ratio: A Novel Noninvasive Index for Predicting Hepatic Fibrosis and Cirrhosis in Chronic Hepatitis B
por: Chen, Baode, et al.
Publicado: (2013)

Diagnostic Estimation of Noninvasive Tests for Hepatic Fibrosis in Chronic Hepatitis B Patients Without a Gold Standard
por: Zheng, Yi Xiang, et al.
Publicado: (2016)

Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C
por: Ladero, Jose M.
Publicado: (2011)

Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update
por: Bojanic, Kristina, et al.
Publicado: (2023)

A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B
por: Zhang, Kang-Ling, et al.
Publicado: (2021)

Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants
por: Lefeuvre, Caroline, et al.
Publicado: (2022)

Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients
por: Rewisha, Eman, et al.
Publicado: (2021)

Non-invasive serum fibrosis markers: A study in chronic hepatitis
por: Abdollahi, Mohammadreza, et al.
Publicado: (2015)

Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients
por: Yuan, Xiaoling, et al.
Publicado: (2019)

Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Cheng, Jieyao, et al.
Publicado: (2015)

Noninvasive Biomarkers in Assessment of Liver Fibrosis in Patients with HBeAg Negative Chronic Hepatitis B
por: Dimzova, Marija, et al.
Publicado: (2018)

A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B
por: Chen, Yan, et al.
Publicado: (2019)

Determination of liver fibrosis stages in Egyptian chronic hepatitis B patients by a noninvasive tool
por: SERAG, Waleed Mohamed, et al.
Publicado: (2019)

External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
por: Lee, Jae Seung, et al.
Publicado: (2022)

Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C
por: Saito, Masaya, et al.
Publicado: (2015)

Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?
por: Oztas, Erkin, et al.
Publicado: (2015)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis
por: Moriya, Kei, et al.
Publicado: (2021)

Accuracy of noninvasive methods for the diagnosis of liver fibrosis in children with chronic viral hepatitis
por: ElShahawy, A, et al.
Publicado: (2022)

Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B
por: Zeng, Xianghua, et al.
Publicado: (2015)

Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
por: Yan, Li-Ting, et al.
Publicado: (2020)

Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Red Blood Cell Distribution Width Levels Correlate With Liver Fibrosis and Inflammation: A Noninvasive Serum Marker Panel to Predict the Severity of Fibrosis and Inflammation in Patients With Hepatitis B
por: Xu, Wen-Shen, et al.
Publicado: (2015)

Egy-Score as a Noninvasive Score for the Assessment of Hepatic Fibrosis in Chronic Hepatitis C: A Preliminary Approach
por: Alboraie, Mohamed, et al.
Publicado: (2014)

Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link
por: Hernández-Bartolomé, Ángel, et al.
Publicado: (2013)

Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?: Erratum
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jkuj4jkvu6e301i8kh7bqmt3kh